Physician profile
Evan Pike
NPI 1669634143
$10,040.82
in general payments reported to CMS, 2019-2025
9 companies · $7,548 in 2025
The $7,548 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,141 · 2020: $19.40 · 2021: $142 · 2022: $503 · 2023: $232 · 2024: $456 · 2025: $7,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,140 · Food and Beverage: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,140.00 |
| Food and Beverage | $1,095.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $7,278.38 | 2024-2025 | |
| Alcon Vision LLC | $1,980.43 | 2019-2025 | Clareon, Wavelight Ex500 Excimer Laser, Eysuvis |
| New World Medical,INC. | $234.33 | 2022-2025 | Streamline, Clearpath, Kahook Dual Blade |
| Rxsight INC | $216.48 | 2021-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Bausch & Lomb Americas INC. | $171.65 | 2022-2024 | Envista Mx60 Iol |
| Johnson & Johnson Surgical Vision, INC. | $69.03 | 2021 | |
| Glaxosmithkline, LLC. | $39.85 | 2022 | |
| Dompe US, INC. | $31.27 | 2023 | Oxervate |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Pike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.